Compound details
6-(3,4-Methylenedioxyphenyl)-3,5-hexadien-2-one
| Compound ID | CDAMM02444 |
|---|---|
| Common name | 6-(3,4-Methylenedioxyphenyl)-3,5-hexadien-2-one | IUPAC name | 6-(1,3-benzodioxol-5-yl)hexa-3,5-dien-2-one |
| Molecular formula | C13H12O3 |
| Retention time | 9.88 |
|---|---|
| Adduct | [M+NH4]+ |
| Actual mz | 234.113 | Theoretical mz | 234.113 |
| Error | 1.61 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.3644 |
| Inchi key | IDYPDRFMVHXYEC-HZDAAVBUSA-N |
|---|---|
| Smiles | O=C(C=CC=CC1=CC=C2OCOC2=C1)C |
| Superclass | Organoheterocyclic compounds |
| Class | Benzodioxoles |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P27338 | MAOB | Monoamine oxidase B | T83011 | SEA |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SEA |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P20701 | ITGAL | Intercellular adhesion molecule (ICAM-1), Integrin alpha-L/beta-2 | T35640 | SEA |
| P10276 | RARA | Retinoic acid receptor alpha | T94085 | SEA |
| P05362 | ICAM1 | Intercellular adhesion molecule-1 | T26203 | SEA |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SEA |
| Q9Y463 | DYRK1B | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | T82720 | SEA |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SEA |
| Q00535 | CDK5 | Cyclin-dependent kinase 5/CDK5 activator 1 | T20973 | SEA |
| P17936 | IGFBP3 | Insulin-like growth factor binding protein 3 | T33455 | SEA |
| P24530 | EDNRB | Endothelin receptor ET-B | T92828 | SEA |
| Q92630 | DYRK2 | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | T39486 | SEA |
| P19438 | TNFRSF1A | Tumor necrosis factor receptor R1 | T86552 | SEA |
| Q16236 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | T88505 | SEA |
| P13631 | RARG | Retinoic acid receptor gamma | T82146 | SEA |
| P10826 | RARB | Retinoic acid receptor beta | T61657 | SEA |
| Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | T65236 | SEA |
| P51843 | NR0B1 | Orphan nuclear receptor DAX-1 | T23191 | SEA |
| Q7RTX1 | TAS1R1 | Taste receptor | T41263 | SEA |
| P05107 | ITGB2 | Integrin beta-2 | T10513 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T35640 | DI0351 | Psoriasis | [ICD-11: EA90] | P20701 | ITGAL |
| T35640 | DI0436 | Visual system disease | [ICD-11: 9E1Z] | P20701 | ITGAL |
| T94085 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10276 | RARA |
| T94085 | DI0251 | Mature T-cell lymphoma | [ICD-11: 2A90] | P10276 | RARA |
| T26203 | DI0436 | Visual system disease | [ICD-11: 9E1Z] | P05362 | ICAM1 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T20973 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q00535 | CDK5 |
| T33455 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P17936 | IGFBP3 |
| T92828 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P24530 | EDNRB |
| T92828 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P24530 | EDNRB |
| T86552 | DI0060 | Brain cancer | [ICD-11: 2A00] | P19438 | TNFRSF1A |
| T86552 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P19438 | TNFRSF1A |
| T88505 | DI0038 | Ataxic disorder | [ICD-11: 8A03] | Q16236 | NFE2L2 |
| T82146 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P13631 | RARG |
| T82146 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P13631 | RARG |
| T82146 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P13631 | RARG |
| T82146 | DI0277 | Muscle calcification/ossification | [ICD-11: FB31] | P13631 | RARG |
| T82146 | DI0351 | Psoriasis | [ICD-11: EA90] | P13631 | RARG |
| T61657 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P10826 | RARB |
| T65236 | DI0100 | Contraceptive management | [ICD-11: QA21] | Q99527 | GPER1 |
| T41263 | DI0078 | Cholera | [ICD-11: 1A00] | Q7RTX1 | TAS1R1 |
| T10513 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P05107 | ITGB2 |